Cellular senescence is a stable growth arrest that is implicated in tissue ageing and cancer. Senescent cells are characterized by an upregulation of proinflammatory cytokines, which is termed the senescence-associated secretory phenotype (SASP). NAD + metabolism influences both tissue ageing and cancer. However, the role of NAD + metabolism in regulating the SASP is poorly understood. Here, we show that nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the NAD + salvage pathway, governs the proinflammatory SASP independent of senescence-associated growth arrest. NAMPT expression is regulated by high mobility group A (HMGA) proteins during senescence. The HMGA-NAMPT-NAD + signalling axis promotes the proinflammatory SASP by enhancing glycolysis and mitochondrial respiration. HMGA proteins and NAMPT promote the proinflammatory SASP through NAD + -mediated suppression of AMPK kinase, which suppresses the p53-mediated inhibition of p38 MAPK to enhance NF-κB activity. We conclude that NAD + metabolism governs the proinflammatory SASP. Given the tumour-promoting effects of the proinflammatory SASP, our results suggest that anti-ageing dietary NAD + augmentation should be administered with precision.
High-throughput Screening Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 5 Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 6 Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA. 7 Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, PA, USA. *e-mail: rzhang@wistar.org C ellular senescence was initially identified as a loss of proliferative capacity after extended culture, which is known as replicative senescence (RS) 1 . In addition, senescence can be induced by a number of stresses, including activation of oncogenes or damage induced by chemotherapeutics 2, 3 . RS is thought to have evolved to limit cancer growth, and oncogene-induced senescence (OIS) underscores the tumour suppressive role of senescence, while the eventual RS of non-cancerous cells may contribute to tissue ageing 2, 4 . Senescent cells also have non-cell autonomous activities, exemplified by the secretion of inflammatory cytokines and chemokines, which is termed the SASP 2 . The SASP plays a context-dependent role in cancer 2 . The net effect of the SASP is mostly detrimental in tumours because it promotes several hallmarks of cancer, including tumour growth, while the elimination of senescent cells delays tumorigenesis 5 . Gene transcription of SASP factors is temporally regulated 6, 7 , whereby the first wave of SASP factors such as transforming growth factor-β1 (TGF-β1) and TGF-β3 are typically immunosuppressive. In contrast, the second wave of the SASP often consists of proinflammatory factors such as interleukin-1β (IL-1β), IL-6 and IL-8 6, 7 .
High mobility group proteins are non-histone chromatinbound proteins that regulate gene transcription by altering chromatin architecture 8, 9 . For example, HMGA proteins such as HMGA1 and HMGA2 bind to DNA without sequence specificity to increase accessibility of the chromatin to transcription factors 10 . HMGA proteins are often overexpressed in cancer, and high levels portend a poor prognosis in a number of cancer types 8 . HMGA proteins promote senescence by regulating chromatin structure 11 . However, the target genes of HMGA proteins and whether these proteins play a role in regulating the SASP during senescence are unknown.
NAD + plays a critical role in tissue ageing and cancer 12, 13 . NAMPT is the rate-limiting enzyme in salvage NAD + biogenesis 14, 15 . Both NAMPT and NAD + levels are decreased during RS and tissue ageing 12, 13 . In addition, cells that undergo mitochondrial dysfunction-associated senescence have lower NAD + /NADH ratios 16 . Indeed, supplementation with NAD + precursors such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) may represent a preventive approach for ageing and its associated pathophysiological disorders 12, 13, 17, 18 . Notably, such supplements for NAD + augmentation have recently entered clinical trials as nutraceuticals. In addition, NAMPT and NAD + play a crucial role in cancers and NAD biosynthesis is often upregulated in tumour cells 13 . However, the role of NAMPT-regulated NAD + biogenesis in regulating the SASP is unknown. Here, we show that the NAMPTregulated NAD + biogenesis pathway governs the strength of the proinflammatory SASP observed during senescence.
Results
HMGA proteins regulate NAMPT expression. To identify HMGA1 target genes during senescence, we performed HMGA1 chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) analysis in proliferating and oncogenic RAS-induced senescent IMR90 cells. Through cross-referencing HMGA1 ChIPseq with RNA sequencing (RNA-seq) datasets and comparing proliferating versus oncogenic RAS-induced senescent IMR90 cells, we identified NAMPT as a top HMGA1 target gene whose expression is NAD + metabolism governs the proinflammatory senescence-associated secretome increased in senescent cells ( Supplementary Fig. 1a ). The differential HMGA1 peak in OIS cells is ~500 bp upstream of the transcription start site ( Supplementary Fig. 1b ), indicating that the HMGA1 binding site may function as an enhancer in regulating NAMPT expression. Indeed, we validated that the association of HMGA1 with the site was significantly enhanced during OIS (Fig. 1a ). This also correlated with an increase in the epigenetic enhancer markers such as lysine 4 monomethylated histone H3 (H3K4me1) and lysine 27 acetylated histone H3 (H3K27Ac) (Fig. 1a ). In addition, we validated that NAMPT expression is upregulated during OIS (Fig. 1b,c) . Knockdown of HMGA1 suppressed NAMPT upregulation during OIS (Fig. 1b,c) . Similar observations were also made with HMGA2 knockdown (Fig. 1d,e ). Conversely, ectopic HMGA1 upregulated NAMPT expression ( Fig. 1f ). Consistent with previous reports 11 , ectopic HMGA1 promoted senescence as evidenced by markers such as senescence-associated β-galactosidase (SA-β-gal), cell growth arrest, decreased cyclin A and upregulated p16 ( Fig. 1g-i) . Notably, these senescence markers were not affected by NAMPT knockdown in established senescent cells induced by ectopic HMGA1 (Fig. 1f-i ; Supplementary Fig. 1c ). Together, we conclude that HMGA proteins upregulate NAMPT during OIS through an enhancer element.
NAMPT promotes the proinflammatory SASP. We next sought to examine the potential role of HMGA1-regulated NAMPT during senescence. Consistent with previous reports 11 , knockdown of HMGA1 at the time of senescence initiation suppressed senescence induced by oncogenic RAS ( Supplementary Fig. 2a-d) . Similarly, inhibition of NAMPT by knockdown or by treatment with the small-molecule inhibitor FK866 19 suppressed RAS-induced senescence at the time of initiation ( Supplementary Fig. 2a-d) . Notably, NAMPT upregulation coincided with the upregulation of genes in the second, proinflammatory, SASP wave such as IL1B, IL6 and IL8 ( Fig. 2a-c ), but not with the upregulation of genes in the first, immuosuppressive, wave of SASP such as TGFB1 and TGFB3 ( Supplementary Fig. 2e ). Indeed, knockdown of HMGA1 or inhibition of NAMPT via either knockdown or with FK866 treatment at the time of senescence initiation suppressed the proinflammatory SASP ( Supplementary Fig. 2f ). It is possible that the observed suppression of the SASP is an indirect effect of the suppression of senescence and its associated growth arrest through the inhibition of HMGA1 or NAMPT. However, we established that knockdown of HMGA1 or NAMPT, or inhibition of NAMPT activity by FK866 treatment, did not affect the growth and expression of markers of senescence in the established OIS cells ( Fig. 2d ; Supplementary  Fig. 2g -i). Meanwhile, proinflammatory SASP gene expression was significantly inhibited by knockdown of HMGA1 or NAMPT or with FK866 treatment in the established OIS cells ( Fig. 2e,f ). This finding was confirmed by using SASP protein antibody arrays enhancer of NAMPT identified by HMGA1 ChIP-seq using the indicated antibodies or an isotype-matched IgG control during OIS (n = 3 independent experiments). b,c, HMGA1 in fully established senescent cells was knocked down using two independent shRNAs. Expression of NAMPT mRNA was determined by qRT-PCR (b) (n = 3 independent experiments) or the indicated proteins were determined by immunoblotting (c). d, In established senescent cells, HMGA2 was knocked down using two independent shRNAs and expression of the indicated proteins was determined by immunoblotting. e, ChIP analysis of the enhancer of NAMPT identified by HMGA1 ChIP-seq using an anti-HMGA2 antibody or an isotype-matched IgG control during OIS (n = 3 independent experiments). f,g, Cells with or without ectopic V5-tagged HMGA1 expression and with or without NAMPT knockdown were examined for the expression of the indicated proteins by immunoblotting (f) or subjected to SA-β-gal staining or colony formation assays (g). Scale bars, 100 μm. h,i, The percentage of SA-β-gal-positive cells (h) and the integrated intensity of the colonies formed by the indicated cells (i) were quantified using NIH Image J software (n = 3 independent experiments). All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test. Statistical source data are provided in Supplementary Table 1 . Unprocessed original scans of all blots with size markers are shown in Supplementary Fig. 8 . . h, V5-tagged HMGA1-overexpressing cells had NAMPT knocked down, and expression of NAMPT and the indicated SASP genes were determined using qRT-PCR (n = 3 independent experiments). i,j, In established senescent cells, HMGA1 was knocked down with or without ectopic expression of a FLAG-tagged wild-type (WT) or catalytically inactive NAMPT. The expression of the indicated proteins was determined by immunoblotting (i). Expression of the indicated SASP genes was determined by qRT-PCR (n = 3 independent experiments) (j). All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test. Statistical source data are provided in Supplementary Table 1 . Unprocessed original scans of all blots with size markers are shown in Supplementary Fig. 8 .
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( Fig. 2g ). Consistently, although NAMPT knockdown did not overcome established senescence induced by ectopic HMGA1 (Fig. 1f -i), NAMPT knockdown suppressed the SASP induced by HMGA1 ( Fig. 2h ). Further supporting the notion that the observed effects on the SASP are mediated by NAMPT downstream of HMGA1, ectopic NAMPT rescued the suppression of the SASP induced by HMGA1 knockdown during OIS ( Fig. 2i ,j). Similar findings were also obtained during senescence induced by oncogenic BRAF or by chemotherapeutics such as etoposide ( Supplementary Fig. 2j-q ).
In addition to its cell intrinsic enzymatic activity during NAD + biogenesis, NAMPT is a secreted factor 13 . Indeed, knockdown of either HMGA1 or NAMPT decreased the levels of extracellular secreted NAMPT ( Supplementary Fig. 2r ). However, it is unlikely that secreted extracellular NAMPT contributes to NAD biosynthesis in this setting because of the lack of its substrate, phosphoribosyl pyrophosphate, in tissue culture media 20 . Thus, to determine whether the observed effects are due to its cell intrinsic enzymatic activity, we determined whether the observed rescue by ectopic NAMPT in HMGA1 knockdown OIS cells depends on its enzymatic activity. Indeed, in contrast to wild-type NAMPT, a mutant NAMPT that is deficient in enzymatic activity failed to rescue the SASP ( Fig. 2i -j).
Consistently, similar findings were made through the inhibition of NAMPT activity by FK866 treatment or by NAMPT knockdown (see, for example, Fig. 2f -h). Thus, we conclude that HMGA1 and NAMPT promote the proinflammatory SASP and this depends on the enzymatic activity of NAMPT.
NAD + metabolism drives proinflammatory SASP. Since the enzymatic activity of NAMPT is required for SASP, we used liquid chromatography with tandem mass spectrometry (LC-MS/MS) to profile the changes in steady-state metabolites induced by the inhibition of HMGA1 or NAMPT. Consistent with the role of NAMPT in NAD + metabolism 13 , the most dramatic changes were observed in the levels of NMN, the direct NAMPT metabolite 14, 15 , after knockdown of HMGA1 or NAMPT or treatment with FK866 ( Fig. 3a ). This was validated by measuring NMN levels in these cells ( Fig. 3b ). Consistently, the NAD + /NADH ratio and NAD + levels were significantly increased in OIS cells, which were decreased by knockdown of HMGA1 or NAMPT or treatment with FK866 ( Fig. 3c ; Supplementary Fig. 3a,b ). Similar observations were also made in senescence induced by oncogenic BRAF or etoposide treatment ( Supplementary Fig. 3c,d) . Notably, the mitochondria dysfunction-associated senescence (MiDAS) secretory phenotype is linked to a lower NAD + /NADH ratio 16 . However, OIS with inactivated HMGA1 and NAMPT is different from the MiDAS secretory phenotype because MiDAS secretory factors such as IL-10 and tumour necrosis factor-α (TNF-α) were also suppressed by HMGA1 and NAMPT inhibition ( Supplementary Fig. 3e ). In addition, a temporal analysis revealed that an increase in the NAD + /NADH ratio coincided with the upregulation of NAMPT and the proinflammatory SASP (Figs. 2a-c and 3d). Furthermore, ectopic HMGA1 that increased NAMPT expression was sufficient to increase the NAD + / NADH ratio and NAD + levels, which was suppressed by NAMPT knockdown ( Fig. 3e ; Supplementary Fig. 3f ). This suggests that HMGA1 increases the NAD + /NADH ratio by upregulating NAMPT during senescence. Indeed, ectopic wild-type NAMPT, but not an enzymatic activity-deficient mutant, rescued the decrease in the NAD + /NADH ratio induced by HMGA1 knockdown (Fig. 3f ).
Likewise, the addition of exogenous NMN was sufficient to restore the NAD + /NADH ratio ( Fig. 3g ), which correlated with a restoration of the decrease in the proinflammatory SASP induced by knockdown of HMGA1 or NAMPT or with FK866 treatment (Fig. 3h ). Thus, we conclude that NAMPT functions downstream of HMGA1 to promote the proinflammatory SASP by increasing the NAD + /NADH ratio. We next performed stable isotope tracer analysis using 13 C 6glucose. Knockdown of HMGA1 or NAMPT or FK866 treatment significantly decreased intracellular pyruvate and lactate levels ( Fig. 3i-k ), suggesting that there was an overall decrease in glycolysis, which correlated with a decrease in glucose uptake and extracellular acidification ( Fig. 3l ,m; Supplementary Fig. 3g ). In addition, mitochondria respiration was suppressed in these cells, as evidenced by a decrease in oxygen consumption ( Fig. 3n ; Supplementary Fig. 3h ).
NAD + metabolism promotes cancer progression. We next determined the effects of NAD + metabolism-regulated proinflammatory SASP in vitro using a co-culture of the OIS IMR90 cells with TOV21G ovarian cancer cells. Compared with controls, OIS IMR90 cells stimulated the growth of the co-cultured TOV21G cancer cells ( Fig. 4a) . Notably, knockdown of HMGA1 or NAMPT or treatment with the NAMPT inhibitor FK866 in the established OIS cells significantly suppressed this growth stimulation ( Fig. 4a ). We next determined the effects of NAD + metabolism in regulating the proinflammatory SASP in vivo. To do so, we utilized a pancreatic cancer mouse model in which the proinflammatory SASP promotes tumour progression in a paracrine SASP-dependent and intrinsic senescence-associated growth arrest-independent manner 21 . Specifically, mice expressing Cre recombinase-inducible lox-STOP-lox (LSL)-Kras G12D were crossed with mice expressing Cre under the control of the pancreasspecific p48 promoter (hereafter referred to as KC mice). These mice develop pancreatic intraepithelial neoplasia (PanINs), precursors to malignancy, which contain senescent cells 22 . At 8 weeks of age, KC mice were given intraperitoneal injections of vehicle control, NMN (500 mg per kg daily) or treated with FK866 (25 mg per kg daily) for 13 days. Mice were killed the day after the last injection and pancreata were harvested for analyses. Notably, NMN treatment resulted in a significant decrease in the proportion of normal acinar area in pancreata compared with controls, indicative of an increase in the amount of precancerous and cancerous lesions (Fig. 4b,c ). Indeed, there was a significant increase in the amount of desmoplastic tissue in NMN-treated pancreata compared with controls, as indicated by Masson trichrome staining ( Fig. 4d,e ). This correlated with an increase in IL1B, IL6 and IL8 expression and an increase in immune cell infiltration (such as CD3-positive and F4/80-positive cells) in NMN-treated pancreata ( Fig. 4f-j) . Notably, NAMPT expression positively correlated with the expression of a number of SASP genes in human PanINs ( Supplementary Fig. 4 ). Consistent with the findings that NAMPT inhibition suppresses senescence at the time of initiation ( Supplementary Fig. 2a-d ), FK866 treatment suppressed the expression of IL1B, IL6 and IL8 and senescence markers such as SA-β-gal, p16 and p21 (Fig. 4f ,k-n). Indeed, FK866 treatment did not decrease the acinar area, intensity of Masson trichrome staining or immune cell infiltration compared with KC controls (Fig. 4b-j ), suggesting tumour progression that is associated with overcoming senescence. In addition, the expression of senescence markers such as SA-β-gal, p16 and p21 was not decreased by NMN treatment (Fig. 4k-n) . Notably, nicotinamide (NAM), a substrate of NAMPT, stimulated TOV21G tumour growth in a xenograft mouse model, and inducible NAMPT knockdown suppressed the observed growth stimulation ( Fig. 4o,p ). This suggests that the observed effects are due to the growth of cancer cells. Taken together, these data support the notion that NMN treatment enhances the inflammatory environment in the pancreas to accelerate pancreatic cancer progression.
AMPK signalling mediates the proinflammatory SASP induced by NAD + . Consistent with the notion that a decrease in the NAD + / NADH ratio suppresses energy production 23 , the ADP/ATP ratio was significantly increased by knockdown of HMGA1 or NAMPT, which was suppressed by exogenous NMN supplementation ( Fig. 5a ). An increase in the ADP/ATP ratio activates AMPK kinase 24 . Knockdown of HMGA1 or NAMPT increased phosphorylated-AMPK expression, which was rescued by NMN supplementation (Fig. 5b,c experiments) and NAD + /NADH ratios (c) were determined in the indicated cells. OXPHOS, oxidative phosphorylation; TCA cycle, tricarboxylic acid cycle. d, Cells were induced to senesce by oncogenic RAS and analysed for the NAD + /NADH ratio at the indicated time points. e, Cells with or without ectopic V5-tagged HMGA1 expression with or without NAMPT knockdown were examined for the NAD + /NADH ratio. f, The NAD + /NADH ratio was determined in established senescent cells with or without HMGA1 knockdown and with or without ectopic expression of a FLAG-tagged WT or catalytically inactive NAMPT. g,h, In established senescence cells, HMGA1 or NAMPT were knocked down using the indicated shRNAs. NAMPT activity was also inhibited by FK866 treatment. Under these conditions, cells were treated with NMN, and the NAD + /NADH ratio (g) and expression of the indicated SASP genes (h) were determined by qRT-PCR. i-k, Cells from the conditions in a were incubated for 6 h in the presence of [ 13 C 6 ]-glucose, and intracellular metabolites were extracted for analysis by LC-MS to evaluate the glycolytic flux in the form of pyruvate (i) and lactate (j) and mitochondrial respiration rates as indicated by citrate production (k). Data were normalized based on the protein concentration. l, Cells from conditions in a were incubated with a fluorescent glucose analogue (2-NBDG) and analysed by flow cytometry for glucose uptake. m,n, Cells from the conditions in g were analysed using Seahorse Bioanalyzer XFe96 for ECARs (m) and OCRs (n). Data were normalized based on the protein concentration. n = 3 independent experiments unless otherwise stated. All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test. Statistical source data are provided in Supplementary Table 1 . o, Immunoblot of the indicated protein in TOV21G cells containing doxycycline (DOX)-inducible knockdown of NAMPT with or without doxycycline treatment. p, TOV21G and oncogene-induced senescent IMR90 cells were subcutaneously co-injected into the right dorsal flank of 6-8-week-old NSG female mice. The mice (n = 9 mice per group) were treated with vehicle control, NAM (500 mg per kg intraperitoneal injection every other day) for 17 days. Tumour growth in the indicated treatment groups was measured at the indicated time points. All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test. Statistical source data are provided in Supplementary Table 1 . Unprocessed original scans of all blots with size markers are shown in Supplementary Fig. 8 . C 25 partially rescued the decrease in the SASP induced by HMGA1 or NAMPT knockdown or FK866 treatment ( Fig. 5d-f ). In addition, the serine 15 residue of p53 is a target of AMPK 26 , and p53 is known to play a role in suppressing the SASP 27 . Indeed, knockdown of HMGA1 or NAMPT increased p53 phosphorylation, while NMN supplementation suppressed the observed increase in p53 phosphorylation (Fig. 5b,c) . Inhibition of the activity of nicotinamide mononucleotide adenylyltransferase (NMNAT), which converts NMN into NAD + downstream of NAMPT, by gallotannin (5 μM) also suppressed the SASP 28 ( Supplementary Fig. 5a,b ). p53 restrains . d-f, In established senescent cells, HMGA1 (d) or NAMPT (e) was knocked down using the indicated shRNAs or treated with FK866 (f). Under these conditions, cells were treated with compound C (CC, 50 nM), an AMPK inhibitor. Expression of the indicated SASP genes was determined by qRT-PCR (n = 3 independent experiments). g, In established senescent cells, HMGA1 or NAMPT was knocked down using the indicated shRNAs or treated with FK866. Under these conditions, cells were treated with NMN, and NF-κB reporter activity was determined (n = 3 independent experiments). All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test. Statistical source data are provided in Supplementary Table 1 .
Unprocessed original scans of all blots with size markers are shown in Supplementary Fig. 8 .
SASP through p38 MAPK activation 29 . Consistently, p38 MAPK activation was suppressed by knockdown of HMGA1 or NAMPT, which was rescued by exogenous NMN (Fig. 5b,c) . Finally, p38 MAPK increased NF-κB activity, which plays a key role in promoting the SASP 29 . Indeed, activation of p65, the regulatory subunit of NF-κB, was suppressed by knockdown of HMGA1 or NAMPT, and this effect was rescued by NMN supplementation (Fig. 5b,c ). This correlated with the observed changes in NF-κB activity in these cells (Fig. 5g ). Although CCAAT enhancer binding protein-β (CEBPβ) plays a key role in driving the proinflammatory SASP 6 , its . j, TOV21G cells overexpressing HMGA1 or NAMPT, or supplemented with NMN, were induced to senesce using etoposide (Eto.; 50 μM for 48 h), and expression of the indicated SASP genes was determined by qRT-PCR (n = 3 independent experiments). All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test.
Statistical source data are provided in Supplementary Table 1 . Unprocessed original scans of all blots with size markers are shown in Supplementary Fig. 8 .
expression was not affected by knockdown of HMGA1 or NAMPT or FK866 treatment ( Supplementary Fig. 5c,d ). This suggests that HMGA1 and NAMPT regulate the proinflammatory SASP through the NAD + /NADH ratio independent of CEBPβ expression.
NAD + metabolism governs the strength of the proinflammatory SASP. Consistent with previous reports 30, 31 , NAMPT was downregulated during RS (Fig. 6a,b) , and NAMPT knockdown or inhibition by FK866 treatment alone induced senescence ( Supplementary  Fig. 6a-c) . This correlated with a downregulation of HMGA1 and a decrease in the association of HMGA1 with the NAMPT enhancer element (Fig. 6a,c) . Consistently, the NAD + /NADH ratio was decreased during RS ( Supplementary Fig. 6d ). Although proinflammatory SASP genes are upregulated during RS, their expression was significantly higher during OIS ( Supplementary Fig. 6e ). Indeed, the growth stimulation of co-cultured TOV21G cancer cells by OIS was significantly stronger than in replicative senescent cells (Fig. 6d ). In addition, NMN enhanced the SASP in RAS-induced OIS cells, and the secretion of SASP factors were validated by protein arrays (Fig. 6e,f) . This correlated with an increase in the NAD + / , senescent late passage (PD90) and late passage expressing oncogenic RAS (PD90) were compared. Cells were examined for expression of the indicated proteins by immunoblotting (a), NAD + / NADH ratio (b) and expression of the indicated SASP genes using qRT-PCR (c) (n = 3 independent experiments). d-g, The indicated cells with or without NMN supplementation were compared. Cells were examined for the indicated proteins by immunoblotting (d), the NAD + /NADH ratio (e), the expression of the indicated SASP genes using qRT-PCR (f), and the effect on the growth of co-cultured TOV21G cancer cells (g). n = 3 independent experiments. All graphs represent the mean ± s.d. P values were calculated using a two-tailed t-test. Statistical source data are provided in Supplementary Table 1 .
Unprocessed original scans of all blots with size marker are shown in Supplementary Fig. 8 . h, Schematic of the mechanism by which NAD + metabolism drives the high proinflammatory SASP. A high proinflammatory SASP accompanies OIS that is driven by HMGA-mediated NAMPT expression and NAD + metabolism as well as DNA damage signalling (large box with solid black outline). NAD + metabolism supports metabolic changes and signalling that leads to the activation of NF-κB signalling and the expression of genes associated with high proinflammatory SASP. A low proinflammatory SASP that accompanies RS is driven primarily through DNA damage-mediated p38 MAPK activation, but devoid of HMGA-mediated NAMPT expression (box with dashed outline).
NADH ratio, NF-κB promoter activity and an enhanced growth stimulation of co-cultured TOV21G cancer cells ( Fig. 6g-i) . Similar SASP enhancement was also observed for NAM and nicotinic acid supplementation ( Supplementary Fig. 6f,g) . Finally, ectopic expression of HMGA1 or NAMPT or NMN supplementation enhanced etoposide-induced SASP in TOV21G ovarian cancer cells (Fig. 6j ). This suggests that NAD + metabolism downstream of HMGA1 and NAMPT may determine the strength of the proinflammatory SASP. Consistently, senescence induced by the inhibition of NAMPT activity (via knockdown or FK866 treatment) was not associated with the strong proinflammatory SASP ( Supplementary Fig. 6h,i) . Indeed, compared with OIS, AMPK, p53 and the DNA damage marker γH2AX were activated at a higher level, while p38 MAPK and p65 were activated at a lower level, in replicative senescent cells (Fig. 6a ). This suggests that NAD + /NADH regulates AMPK signalling downstream of HMGA1 and NAMPT, which governs the strength of the proinflammatory SASP. Consistent with previous reports, although DNA damage was induced during OIS, it was restrained during late-stage OIS 32, 33 ( Supplementary Fig. 6j ). Moreover, compared with OIS, both extracellular acidification rates (ECARs) and oxygen consumption rates (OCRs) were significantly lower in RS cells ( Supplementary Fig. 6k,l) . This result supports the notion that glycolysis and mitochondria respiration promote NAD + -dependent SASP. We next determined whether oncogenic RAS is sufficient to increase NAD + biogenesis through HMGA1-regulated NAMPT in replicative senescent cells. Indeed, RAS increased HMGA1 and NAMPT levels in replicative senescent cells, which correlated with a decrease in AMPK, an increase in p38 and p65 activation, and an increase in NF-κB reporter activity ( Fig. 7a; Supplementary Fig. 7a) . Notably, the NAD + /NADH ratio was increased in these cells (Fig. 7b) , which correlated with a significant increase in the SASP (Fig. 7c ). Since ectopically expressed NAMPT has both cell intrinsic and extracellular activity 13 , we performed the NMN supplementation experiment instead of NAMPT ectopic expression to limit extracellular NAMPT ligand activity. Indeed, exogenous NMN supplementation in replicative senescent cells suppressed AMPK and p38 activity, and increased p38 and p65 activation, and NF-κB promoter activity ( Fig. 7d; Supplementary Fig. 7b ). This correlated with an increase in the NAD + /NADH ratio and an enhancement of the proinflammatory SASP and stimulation of the growth of cocultured TOV21G ovarian cancer cells ( Fig. 7e-g) . Notably, RAS or NMN supplementation did not affect senescence and the associated cell growth arrest ( Supplementary Fig. 7c-e ). Thus, these data support a model whereby an increase in the NAD + /NADH ratio converts a low proinflammatory SASP during RS into a high proinflammatory SASP (Fig. 7h ).
Discussion
HMGA1 promotes senescence-associated growth arrest 11 . Here, we showed that HMGA1 plays an instrumental role in the proinflammatory SASP by upregulating NAMPT through an enhancer element. Thus, HMGA1 couples the senescence-associated cell growth arrest and the proinflammatory SASP during senescence. Interestingly, HMGA1 is often upregulated in human cancers and its overexpression correlates with a poor prognosis in many cancer types 8, 34 . However, the tumour suppressive effects of HMGA proteins depend on the integrity of the senescence machinery, and HMGA proteins become oncogenic in cells that have bypassed senescence 11 . Thus, HMGA1 is no longer tumour suppressive in senescence-bypassed cancer cells. Our data show that inhibition of HMGA1 suppresses the SASP. This raises the possibility that targeting HMGA1-regulated NAMPT may be an effective approach to suppress a proinflammatory tumour microenvironment in HMGA1-overexpressing tumours. Indeed, NAMPT inhibitors are already in clinical trials. Thus, senescence-inducing cancer thera-peutics, including chemotherapy, may benefit from a combination with NAMPT inhibitors.
Our results show that NAD + metabolism plays a key role in determining the strength of the proinflammatory SASP. High SASPassociated senescence such as OIS is predominantly driven by a high NAD + /NADH ratio, while low SASP-associated senescence such as RS is primarily driven by DNA damage. This is consistent with the reported role of DNA damage in the SASP 35 . These differences in upstream signalling determined the strength of p38 MAPK and NF-κB signalling to ultimately dictate the strength of the SASP during different types of senescence. Indeed, increasing the NAD + /NADH ratio in RS by ectopic oncogenic RAS or NMN supplementation significantly enhanced the proinflammatory SASP. Notably, the proinflammatory SASP is tumorigenic 36, 37 . Consistently, NMN supplementation promoted pancreatic ductal adenocarcinoma progression in a mouse model driven by oncogenic Kras. Thus, NAD + -augmenting dietary supplements may be tumorigenic in vivo in stressed conditions such as premalignant senescent lesions induced by activated oncogenes. However, it has been extensively documented that NMN supplements can alleviate certain age-related pathophysiological conditions, and NAD + -augmenting supplements, such as NMN, are currently in clinical development as nutraceuticals 12 . Thus, a dietary NAD + -augmenting supplement should be administered with precision to balance the advantageous anti-ageing effects with potential detrimental pro-tumorigenic side effects. In summary, our results show that NAD + metabolism governs the proinflammatory SASP. Thus, our study will have far-reaching implications for understanding proinflammatory SASP regulation during senescence and precisely administering NAD + -augmenting anti-ageing dietary supplements such as NMN.
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Metabolite tracing and measurements. For steady-state metabolite measurements, cells were seeded into 10-cm dishes at the concentration of 1 × 10 6 cells per dish. Cells were washed twice using cold PBS and metabolites were extracted using extraction solution (80% LC-MS-grade methanol, 20% Milli-Q water and 0.1 μM internal standard). Samples were processed in a 4 °C cold room and incubated on dry ice for 10 min before being vortexed for 2 min. Last, samples were centrifuged at maximum speed for 15 min at 4 °C and the supernatant was analysed by LC-MS/MS. Targeted quantitation of steady-state metabolites was performed on a SCIEX 5500 QTRAP triple quadrupole mass spectrometer equipped with a Turbo V source and coupled to a Shimadzu Nexera UHPLC system. A total of 5 μl of each sample were injected onto a ZIC-pHILIC 2.1-mm i.d × 150 mm column (EMD Millipore). Buffer A was 20 mM ammonium carbonate, 0.1% ammonium hydroxide, and buffer B was acetonitrile. The chromatographic gradient was run at a flow rate of 0.150 ml min -1 for 80-20% B over 20 min, 20-80% B over 0.5 min, and held at 80% B for 7.5 min. Metabolites were targeted in positive and negative ion modes separately for a total of 161 selected reaction monitoring transitions. Electrospray ionization voltage was +5,500 V in positive ion mode and −4,500 V in negative ion mode. The dwell time was 20 ms per transition in positive ion mode (46 total transitions), and 5 ms per transition in negative ion mode (115 total transitions). A minimum of nine data points were acquired per detected metabolite. Peak areas from the total ion current for each metaboliteselected reaction monitoring transition were integrated using the MultiQuant v.3.0.2 software (SCIEX). The metabolic tracing data are provided in Supplementary Table 1 .
For stable isotope tracer analysis using [ 13 C 6 ]-glucose, cells were seeded at the concentration of 3 × 10 5 cells per well and incubated with 25 mM of the [ 13 C 6 ]glucose tracer in glucose-free medium for 1 and 6 h. Following incubation, cells were washed with PBS and incubated with 500 μl of extraction solution for 5 min at 4 °C. The extraction solution from each sample was collected and centrifuged at maximum speed for 10 min at 4 °C. The resulting supernatant was used for analysis. Metabolite measurements were normalized based on the protein concentration. LC-MS metabolite flux analysis was performed on a Thermo Scientific Q Exactive Plus mass spectrometer equipped with a HESI II probe and coupled to a Shimadzu Nexera UHPLC system. Column and LC conditions were as described above. The mass spectrometer was operated in full-scan, polarity switching mode with the spray voltage set to 3.2 kV in positive ion mode and 2.5 kV in negative ion mode. The heated capillary was set at 275 °C, the HESI probe at 350 °C, and the S-lens RF level at 45. The gas settings for sheath, auxiliary and sweep were 40, 10 and 1 unit, respectively. The mass spectrometer was set to repetitively scan m/z from 70 to 1,000, with the resolution set at 70,000, the AGC target at 1E6, and the maximum injection time at 80 ms. Metabolite identification and quantitation were performed using TraceFinder (Thermo Fisher Scientific).
The NAD + /NADH ratio was determined using a NAD/NADH-Glo Assay (Promega, G9071) according to the manufacturer's standard protocol. The ADP/ ATP ratio was determined using an ADP/ATP Ratio Assay kit (Sigma, cat. no. MAK135) according to the manufacturer's standard protocol. Luminscence signals from the NAD/NADH-Glo Assay and ADP/ATP Ratio Assay kits were measured using a Victor X3 2030 Multilabel Reader (Perkin Elmer). EACRs and cellular OCRs were measured using a Glycolysis Stress Test kit and a Seahorse Bioanalyzer XFe96 (Agilent Technologies) according to the manufacturer's standard protocol. Briefly, cells were seeded at the concentration of 30,000 cells per well in DMEM the day before running the assay. The next day, the cells were incubated with DMEM devoid of glucose and sodium pyruvate (Sigma, cat. no. R1383 supplemented with 10% fetal bovine serum) and loaded on the Seahorse Bioanalyzer XFe96. Working concentrations of compounds used within the glycolysis stress test kit are as followed: glucose at 10 mM, oligomycin A at 2 μM and 2-deoxyglucose at 50 mM. The ECAR is reported in mpH min -1 while the OCR is reported in pmol min -1 . Samples were normalized based on the protein concentration.
Co-culture experiments. Senescent fibroblasts were seeded into 6-well plates to generate a 95% confluent fibroblast monolayer and incubated in a serum-deficient condition for 48 h. Luciferase-expressing ovarian cancer cells (TOV21G cell line) were seeded on top of the fibroblast lawn and incubated for 8 days under the serum-deficient condition. Cells were treated with doxycycline (1 μg ml -1 ) for inducible knockdown of NAMPT in the presence or absence of NAM. Cells were assayed for luminescence using a Dual-Luciferase Reporter Assay system (Promega, cat. no. E1910). Luminescence was measured using a Victor X3 2030 Multilabel Reader (Perkin Elmer).
Cytokine secretion measurements. The antibody array for secreted factors was performed using a Quantibody Human Inflammation Array 3 kit (QAH-INF-3) by RayBioTech based on the manufacturer's instructions. Briefly, conditioned medium was generated from cells following a PBS wash and incubation in serum-free DMEM for 48 h. Conditioned medium was filtered (0.2 μm) and incubated on the array overnight at 4 °C. Following incubation, the array was washed five times with wash buffer I and then two times with wash buffer II at room temperature. The array was then incubated with the biotinylated antibody cocktail for 2 h at room temperature before being washed five times with wash buffer I and then two times with wash buffer II at room temperature. The array was then incubated with Cy3 dye-conjugated streptavidin and incubated in the dark at room temperature for 1 h. Following incubation, the array was washed five times with wash buffer I and then washed two times with wash buffer II before allowing to dry at room temperature in the dark. Cy3 signals were measured using an Amersham Typhoon imaging system and normalized to the cell number from which the conditioned medium was generated.
In vivo pancreatic cancer mouse model. All animal procedures were approved by the New York University (NYU) School of Medicine Institutional Animal Care and Use Committee (IACUC). LSL-Kras G12D and p48-Cre mice were gifts from T. Jacks (Massachusetts Institute of Technology) and D. Bar-Sagi (NYU School of Medicine), respectively. Mice are on a mixed background. At 8 weeks of age, mice received daily intraperitoneal injections of either 500 mg per kg NMN or an equal volume of PBS for 13 days. Where indicated, mice were treated at 8 weeks of age with 25 mg per kg FK866 daily. Mice were killed on day 14, and pancreata were collected for downstream analysis.
Histology and immunohistochemistry. Mouse pancreata were fixed in IHC Zinc fixative (BD Pharminogen) for 48 h and processed for paraffin embedding. Histological, trichrome and immunohistochemical staining were performed at the NYU School of Medicine Experimental Pathology Research Laboratory. The following antibodies were used: anti-F4/80 (Cell Signaling, clone ND) and anti-CD3 (Spring Biosciences, clone SP7). The percentage acinar area was calculated by dividing the number of pixels that constituted a normal acinar area and dividing by the total number of pixels that constituted tissue. The percentage trichrome-stained area was calculated by dividing the number of blue pixels by the total number of tissue pixels. F4/80 was calculated by dividing the number of brown pixels by the total number of tissue pixels. CD3 was calculated by counting the number of CD3positive cells per field of view and averaging the number over 15 fields.
Xenograft mouse model. The protocols were approved by the Wistar IACUC. Cells (TOV21G:senescent fibroblasts at a ratio of 1:1, 2 × 10 6 cells) were suspended in 100 μl PBS:Matrigel (1:1) and unilaterally injected subcutaneously into the right dorsal flank of 6-8-week-old female immunocompromised non-obese diabetic/ severe combined immunodeficiency (NOD/SCID) gamma (NSG) mice. The mice were administered doxycycline-containing food following injection of the cells. Four days after injection of the cells, the mice (n = 9 mice per group) were treated with vehicle control, NAM (500 mg per kg; intraperitoneal injection every other day) for 17 days. NAM was dissolved in water. Tumour size was measured on the indicated days. Tumour size was determined using the following equation: tumour size (mm 3 Corresponding author(s): Rugang Zhang Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
Flowjo was used to determine percentages of apoptotic cells. Images were analyzed using Live Imaging 4.0 software.
Data analysis
Prism 7 for Mac was used for calculating p values.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
The ChIP-seq data was submitted to the Gene Expression Omnibus (GEO) database and can be accessed using accession number: GSE111841 nature research | reporting summary
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Flow Cytometry Plots Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology

Sample preparation
Samples were incubated with 5 uM 2-NBDG (Invitrogen) for two hours, trypsinized and washed with PBS, and run on an LSRII flow cytometer (Becton Dickinson). Analysis was performed using FlowJo Software.
Instrument
FACSCalibur Software FlowJo version 7
Cell population abundance 10000 cells were acquired and analyzed
Gating strategy
Forward and side scatter gating strategy was used to eliminate the cell debris, fragments and pyknotic cells. The gated population was analyzed for 2NBDG (FITC) mean fluorescence intensity. Please see an example in Extended Data Figure 3g .
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
